Oncology On The Go

About Oncology On The Go

Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more. To learn more, you can also visit us on Facebook, Twitter, and LinkedIn!

Publisher

CancerNetwork

Category

science

Language

en

Explicit

No

First episode

6 Jul 2020

Latest episode

21 Oct 2026

Latest episodes

265 episodes in the feed.

1. 

   21 Oct 2026

   S1 Ep239: Discussing Guidelines, New Data, and Earlier Referrals in Multiple Myeloma

   Experts highlight updated findings from CARTITUDE-2, how to mitigate late toxicities, and other key considerations in the modern multiple myeloma landscape.

2. 

   19 Oct 2026

   S1 Ep238: Psycho-Oncology and Palliative Care: Treating the Person, Not Just the Tumor

   In this episode of Oncology On the Go, Daniel C. McFarland, DO, spoke with Ramy Sedhom, MD, about how to build a cancer practice where symptom management and emotional support are part of routine oncology care rather than an outside referral. Sedhom traced his approach to mentorship from Thomas Smith, MD, during his oncology fellowship at Johns Hopkins and to his palliative care training at Memorial Sloan Kettering Cancer Center. Noting that most patients with cancer receive treatment in their local communities, he described a model in which medical oncologists share clinical space with palliative care and psycho-oncology teams. That proximity, he explained, improves access and normalizes supportive care as a standard part of treatment. Using the example of a young mother newly diagnosed with triple-negative breast cancer, he walked through how a real-time message through the electronic medical record can bring a psychologist into the room for a warm handoff before the patient leaves the visit, often leading to ongoing therapy such as cognitive behavioral therapy. McFarland emphasized that therapeutic presence and the ongoing patient-clinician relationship are healing, even though they are difficult to measure or reimburse. He described the use of shared medical visits in his practice and the value of weekly team meetings that include therapists, chaplains, and other staff. Both clinicians discussed proactive distress screening at regular intervals, which Sedhom said can reveal concerns patients may not otherwise raise. They also highlighted the prognostic uncertainty and anticipatory distress faced by patients living for years with EGFR-mutated lung cancer on oral targeted therapy such as osimertinib (Tagrisso), as well as the confusion that can follow a “good prognosis” diagnosis. The conversation also covered lessons psychiatry can offer oncologists, including reframing difficult patient behavior, loosening control of the visit agenda, building rapport before having honest conversations, and accepting ambiguity to help prevent burnout. The two closed by considering whether a broad supportive care umbrella could unite palliative care, psychiatry, psychology, and other disciplines, with McFarland urging clinicians to set aside silos and professional egos for the benefit of patients. McFarland is the director of the Psycho-Oncology Program at Wilmot Cancer Center and a medical oncologist who specializes in head, neck, and lung cancer, in addition to being the psycho-oncology editorial advisory board member for the journal ONCOLOGY®. co-lead of Geriatric Oncology at Penn Cancer Service Line; clinical director of Medical Oncology at Penn Medicine Princeton Health; associate director of Penn Center for Cancer Care Innovation; co-lead of Psychosocial Oncology Services at Penn Medicine Princeton Health; division chief in the Palliative Care Division of Medical Oncology; and a clinical associate professor of medicine (Hematology-Oncology).

3. 

   12 Oct 2026

   S1 Ep237: Is Less More? Antibiotic De-escalation in Hematopoietic Cell Transplants

   • The conversation examines antimicrobial stewardship and its role in microbial resistance prevention and microbiome health in a broad transplant population. • The panel explores when early antibiotic de-escalation may be safe and appropriate for patients undergoing hematopoietic cell transplantation in both adult and pediatrics. • Experts discuss emerging evidence and guidelines supporting shorter courses of gram-negative and gram-positive antibiotic coverage in transplant recipients.

Who has been a guest on Oncology On The Go

Names identified in recent episode analyses. Showing up to five guests.

• Eric K Singhi
• Nicholas James Hornstein
• Marc J Braunstein
• Nerea M Lopetegui-Lia
• MinhTri Nguyen

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

3.0 / 5

5 ratings

Podcast Authority Score: 37 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

44

Social presence

0

YouTube

0

Engagement

77

Contact Oncology On The Go

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Two Onc Docs

• 

  Oncology Brothers

• 

  OncLive® On Air

• 

  CME in Minutes: Education in Oncology & Hematology

• 

  Consider This from NPR

• 

  Oncology Today with Dr Neil Love